Babesiosis
Also known as: Babesiosis, unspecified / Babesiosis (disorder) / Babesia infections
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB01190 | Clindamycin | A lincosamide antibiotic used to treat serious infections caused by susceptible anaerobic, streptococcal, staphylococcal, and pneumococcal bacteria. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB01190 | Clindamycin | Cytochrome P450 3A4 | enzyme |
| DB01190 | Clindamycin | Cytochrome P450 3A5 | enzyme |
| DB01190 | Clindamycin | Alpha-1-acid glycoprotein 1 | carrier |
| DB01190 | Clindamycin | P-glycoprotein 1 | transporter |
| DB01190 | Clindamycin | 50S ribosomal protein L1 | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB06608 | Tafenoquine | 2 | Not Yet Recruiting | 1 |